GSK Plc announced a share buyback of £2 billion as it saw better than expected profit in the fourth quarter. The share ...

By Nikhil Sharma (Reuters) -European shares dipped on Wednesday, as the rise in healthcare companies after Novo Nordisk's ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

London stocks nudged higher in early trade on Wednesday as investors mulled disappointing US tech results and continued to ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.

Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday ...

GSK and the University of Oxford have joined hands to focus on the potential of cancer prevention through vaccination. The ...

Learn more about how GSK is harnessing the power of technology to improve outcomes for people with cancer.